Dermatomyositis induced by hepatitis B virus-related hepatocellular carcinoma: A case report and review of the literature

Internal Medicine

Volumn 56, Issue 14, 2017, Pages 1831-1837

  Chou, Jen Wei ^a,b   Lin, Yin Lan ^b   Cheng, Ken Sheng ^a,b   Wu, Po Yuan ^a,b   Reanne Ju, Teressa ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Dermatomyositis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Paraneoplastic syndrome; Polymyositis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HYDROCORTISONE; LACTATE DEHYDROGENASE; MYOGLOBIN; PREDNISOLONE; TELBIVUDINE; ANTIINFLAMMATORY AGENT;

ABDOMINAL DISTENSION; ADULT; AIRWAY OBSTRUCTION; ASCITES; BLOOD CELL COUNT; BLURRED VISION; CASE REPORT; CHRONIC HEPATITIS B; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DYSPHAGIA; ELECTROMYOGRAPHY; ERYTHEMA; HEADACHE; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; JAUNDICE; LEUKOCYTE DIFFERENTIAL COUNT; LIMB WEAKNESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MIDDLE AGED; MOTOR NERVE CONDUCTION; MUSCLE RIGIDITY; MUSCLE TONE; MYOSITIS; PARANEOPLASTIC SYNDROME; RASH; REVIEW; SCLERA; SKIN BIOPSY; SLURRED SPEECH; TENDON REFLEX; VIRUS LOAD; COMPLICATION; DISEASE EXACERBATION; LIVER TUMOR; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; CARCINOMA, HEPATOCELLULAR; DERMATOMYOSITIS; DISEASE PROGRESSION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PREDNISOLONE; TREATMENT OUTCOME;

EID: 85024363380     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.56.7595     Document Type: Review

References (35)

1. Kao LL, Chung L, Fiorentino DF. Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep 13: 225-232, 2011.
2. Andras C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35: 438-444, 2008.
3. Tiniakou E, Mammen AL. Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol 2015 Oct 1 [Epub ahead of print].
4. Cheng TI, Tsou MH, Yang PS, Sung SM, Chuang VP, Sung JL. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma. J Gastroenterol Hepatol 17: 1239-1240, 2002.
5. Gomez A, Solans R, Simeon CP, et al. Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al. Arthritis Rheum 40: 394-395, 1997.
6. Gray RG, Altman RD, Gottlieb NL. Aberrant serum enzyme patterns in dermatomyositis associated with hepatoma. J Rheumatol 3: 227-232, 1976.
7. Hasegawa K, Uesugi H, Kubota K, et al. Polymyositis as a paraneoplastic manifestation of hepatocellular carcinoma. Hepatogas-troenterology 47: 1425-1427, 2000.
8. Horie Y, Yamada M, Nakai K, et al. Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis. J Gastroenterol Hepatol 4: 101-104, 1989.
9. Inuzuka M, Tomita K, Tokura Y, Takigawa M. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol 144: 416-417, 2001.
10. Kee KM, Wang JH, Lee CM, Changchien CS, Eng HL. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J 27: 834-839, 2004.
11. Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int 29: 595-599, 2009.
12. Kim MJ, Kim JA, Sung MS, Min JK. Hepatocellular carcinoma, polymyositis, rhabdomyolysis, and acute renal failure. J Korean Med Sci 19: 891-894, 2004.
13. Kishore D, Khurana V, Raj A, Gambhir IS, Diwaker A. Hepatocellular carcinoma presenting as polymyositis: a paraneoplastic syndrome. Ann Saudi Med 31: 533-535, 2011.
14. Leaute-Labreze C, Perel Y, Taieb A. Childhood dermatomyositis associated with hepatocarcinoma. N Engl J Med 333: 1083, 1995.
15. Tekaya R, Abdelghni K, Abdelmoula L, Ben Hadj Yahia C, Chaabouni L, Zouari R. Hepatocellular carcinoma with polymyositis as an initial symptom: a case report. Acta Clin Belg 66: 53-54, 2011.
16. Thanapirom K, Aniwan S, Treeprasertsuk S. Polymyositis associated with hepatitis B virus cirrhosis and advanced hepatocellular carcinoma. ACG Case Rep J 1: 167-169, 2014.
17. Toshikuni N, Torigoe R, Mitsunaga M, Omoto A, Nakashima K. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol 12: 1641-1644, 2006.
18. Yang SY, Cha BK, Kim G, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Korean J Intern Med 29: 231-235, 2014.
19. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326: 363-367, 1992.
20. Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL. Estimation of cancer burden attributable to infection in Asia. J Epidemiol 25: 626-638, 2015.
21. Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol 26: 78-88, 2014.
22. Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Ann Clin Lab Sci 33: 39-54, 2003.
23. Qu Q, Wang S, Chen S, Zhou L, Rui JA. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma. Am Surg 80: 191-196, 2014.
24. Vautravers C, Rat P, Cercueil JP, Moreau T, Horiot JC, Chauffert B. Hepatocellular carcinoma presenting as paraneoplastic myasthe-nia gravis. Eur J Intern Med 19: e86-e87, 2008.
25. Coccoli P, Esposito P, Cianciaruso B, et al. Hepatitis C and kidney disease. Dig Liver Dis 39 Suppl 1: S83-S85, 2007.
26. Ferri C, Antonelli A, Mascia MT, et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39 Suppl 1: S13-S21, 2007.
27. Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34: 85-102, 2008.
28. Bohan A. History and classification of polymyositis and dermatomyositis. Clin Dermatol 6: 3-8, 1988.
29. Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 13: 117-124, 2010.
30. Sultan SM, Isenberg DA. Re-classifying myositis. Rheumatology (Oxford) 49: 831-833, 2010.
31. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 2015 Sep 30 (Epub ahead of print).
32. Choy EH, Isenberg DA. Treatment of dermatomyositis and polymyositis. Rheumatology (Oxford) 41: 7-13, 2002.
33. Aggarwal R, Oddis CV. Therapeutic advances in myositis. Curr Opin Rheumatol 24: 635-641, 2012.
34. Bronner IM, van der Meulen MF, de Visser M, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65: 1456-1461, 2006.
35. Yang CH, Wu TS, Chiu CT. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy. Br J Dermatol 157: 587-590, 2007.